MX9205914A - Nuevos derivados de furancarboxilato de amidinonaftilo y sales de adicion de acido de los mismos - Google Patents

Nuevos derivados de furancarboxilato de amidinonaftilo y sales de adicion de acido de los mismos

Info

Publication number
MX9205914A
MX9205914A MX9205914A MX9205914A MX9205914A MX 9205914 A MX9205914 A MX 9205914A MX 9205914 A MX9205914 A MX 9205914A MX 9205914 A MX9205914 A MX 9205914A MX 9205914 A MX9205914 A MX 9205914A
Authority
MX
Mexico
Prior art keywords
group
alkyl
substituted
alkenyl
furancarboxylate
Prior art date
Application number
MX9205914A
Other languages
English (en)
Inventor
Toyoo Nakayama
Seizo Taira
Hiroyuki Kawamura
Masaoki Shibuya
Masahiro Iwaki
Original Assignee
Torii & Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torii & Co Ltd filed Critical Torii & Co Ltd
Publication of MX9205914A publication Critical patent/MX9205914A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Detergent Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Derivados de furancarboxilato de amidinonaftilo de la fórmula I (fórmula I), en donde A es un enlace solo o A denota un grupo alquenilfenilo, grupo alquilfenilo, grupo fenialquelino, grupo fenilalquilo, grupo fenilo, grupo alquilo inferior o grupo alquenilo inferior r que puede tener una cadena lateral, siempre que la cadena lateral pueda formar un anillo o la cadena lateral puede tener un anillo ciclohexilo o grupo alquilo inferior-alquilcarbamoilo inferior y R denota un grupo hidroxilo, grupo alcoxi inferior que puede tener una cadena lateral, grupo alcoxi inferior fenilo, -OA1(OH), grupo amino, y sales de adición de ácido farmacéuticamente aceptable a partir de ahí compuestos nuevos y útiles como productos farmacéuticos.
MX9205914A 1992-02-10 1992-10-15 Nuevos derivados de furancarboxilato de amidinonaftilo y sales de adicion de acido de los mismos MX9205914A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4023848A JPH05213927A (ja) 1992-02-10 1992-02-10 新規フランカルボン酸アミジノナフチルエステル誘導体およびその酸付加塩

Publications (1)

Publication Number Publication Date
MX9205914A true MX9205914A (es) 1993-09-01

Family

ID=12121832

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9205914A MX9205914A (es) 1992-02-10 1992-10-15 Nuevos derivados de furancarboxilato de amidinonaftilo y sales de adicion de acido de los mismos

Country Status (16)

Country Link
EP (1) EP0556024B1 (es)
JP (1) JPH05213927A (es)
KR (1) KR100229254B1 (es)
AT (1) ATE125806T1 (es)
AU (1) AU652076B2 (es)
CA (1) CA2079267A1 (es)
DE (1) DE69300307T2 (es)
DK (1) DK0556024T3 (es)
FI (1) FI925311A (es)
HU (1) HUT63841A (es)
MX (1) MX9205914A (es)
NO (1) NO300633B1 (es)
PL (1) PL174421B1 (es)
RU (1) RU2096410C1 (es)
TW (1) TW232687B (es)
ZA (1) ZA927646B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1030844A1 (en) * 1997-11-10 2000-08-30 Array Biopharma Inc. Compounds which inhibit tryptase activity
US6362216B1 (en) 1998-10-27 2002-03-26 Array Biopharma Inc. Compounds which inhibit tryptase activity
JP3395061B2 (ja) 2000-02-21 2003-04-07 学校法人金沢工業大学 図書館の蔵書自動出納システムと図書館の蔵書出納ロボットならびに図書館の蔵書出納ロボットのハンド機構
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
ES2618024T3 (es) * 2011-06-07 2017-06-20 Ea Pharma Co., Ltd. Derivado de éster de ácido carboxílico heterocíclico
US9024044B2 (en) 2012-06-14 2015-05-05 Ajinomoto Co., Inc. Heteroarylcarboxylic acid ester derivative

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59139357A (ja) * 1983-01-28 1984-08-10 Torii Yakuhin Kk アミジン誘導体
US4563527A (en) * 1984-07-19 1986-01-07 Torii & Co., Ltd. Amidine compounds

Also Published As

Publication number Publication date
PL297964A1 (en) 1993-10-18
EP0556024A1 (en) 1993-08-18
NO924758D0 (no) 1992-12-09
ZA927646B (en) 1993-04-13
ATE125806T1 (de) 1995-08-15
NO924758L (no) 1993-08-11
TW232687B (es) 1994-10-21
FI925311A0 (fi) 1992-11-23
KR930017884A (ko) 1993-09-20
EP0556024B1 (en) 1995-08-02
DE69300307T2 (de) 1996-01-25
AU2537892A (en) 1993-08-12
FI925311A (fi) 1993-08-11
AU652076B2 (en) 1994-08-11
DE69300307D1 (de) 1995-09-07
DK0556024T3 (da) 1995-09-18
JPH05213927A (ja) 1993-08-24
NO300633B1 (no) 1997-06-30
RU2096410C1 (ru) 1997-11-20
HU9203908D0 (en) 1993-04-28
KR100229254B1 (ko) 1999-11-01
CA2079267A1 (en) 1993-08-11
HUT63841A (en) 1993-10-28
PL174421B1 (pl) 1998-07-31

Similar Documents

Publication Publication Date Title
AU680704B2 (en) Cyclic amide derivatives
FI914187A0 (fi) Menetelmä valmistaa kaavan /I/ mukaista 1-metyylikarbapeneemijohdosta
NO306062B1 (no) Syremellomprodukter til bruk ved fremstilling av taxanderivater
DK161832C (da) Analogifremgangsmaade til fremstilling af 1-sulfo-2-azetidinonderivater eller farmaceutisk acceptable salte eller estere deraf
MX9205914A (es) Nuevos derivados de furancarboxilato de amidinonaftilo y sales de adicion de acido de los mismos
PT96003A (pt) Processo para a preparacao de composicoes farmaceuticas, contendo um derivado triazol
ES2082971T3 (es) Esteres de fosfato de acilo y modificacion de proteinas con los mismos.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees